Wcn24-1823 Desensitization Therapy in Hyperimmunized Living Donor Kidney Transplant Recipients and Its Impact on Graft Function and Acute Rejection Rate in the First Year Post-Transplant

Desensitization treatment may increase the possibility of successful kidney transplantation from living and deceased donors in hyperimmunized patients. Decreasing/eliminating levels of donor-specific antibodies, decreasing the incidence of hyperacute rejection, and allowing successful transplantation, with adequate long-term transplant survival.